Pcr Technologies

Polymerase Chain Reaction (PCR) Market (Product - Instruments (Standard PCR, RT-PCR, Digital PCR), Reagents, Consumables; End use - Pharmaceutical & Biotechnology Industries, Clinical Diagnostics Labs and Hospitals, Academic and Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026

  • Rep Id : TMRGL830
  • Published On : Jul 2018
  • No. of Pages : 190
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
            4.3.4. Trends
     4.4. Global PCR Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Product Portfolio Analysis, by Key Players
     5.2. Distributor Analysis, by Key Players
     5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers
     5.4. Market Value Share Analysis (%): by PCR Technology
     5.5 Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder

6. Global PCR Market Analysis and Forecast, by Product
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Product, 2016–2026
            6.3.1. Instruments
                     6.3.1.1. Standard PCR Systems
                     6.3.1.2. RT PCR Systems
                     6.3.1.3. Digital PCR Systems
            6.3.2. Reagents
            6.3.3. Consumables
     6.4. Market Attractiveness, by Product

7. Global PCR Market Analysis and Forecast, by End-user
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by End-user, 2016–2026
            7.3.1. Pharmaceutical and Biotechnology Industries
            7.3.2. Clinical Diagnostics Labs and Hospitals
            7.3.3. Academic and Research Organizations
            7.3.4. Others
     7.4. Market Attractiveness, by End-user

8. Global PCR Market Analysis and Forecast, by Region
     8.1. Key Findings
     8.2. Market Value Forecast, by Region
            8.2.1. North America
            8.2.2. Europe
            8.2.3. Asia Pacific
            8.2.4. Rest of the World
     8.3. Market Attractiveness, by Country/Region

9. North America PCR Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Market Value Forecast, by Product, 2016–2026
            9.2.1. Instruments
                     9.2.1.1. Standard PCR Systems
                     9.2.1.2. RT PCR Systems
                     9.2.1.3. Digital PCR Systems
            9.2.2. Reagents
            9.2.3. Consumables
     9.3. Market Value Forecast, by End-user, 2016–2026
            9.3.1. Pharmaceutical and Biotechnology Industries
            9.3.2. Clinical Diagnostics Labs and Hospitals
            9.3.3. Academic and Research Organizations
            9.3.4. Others
     9.4. Market Value Forecast, by Country, 2016–2026
            9.4.1. U.S.
            9.4.2. Canada
     9.5. Market Attractiveness Analysis
            9.5.1. By Product
            9.5.2. By End-user
            9.5.3. By Country

10. Europe PCR Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product, 2016–2026
            10.2.1. Instruments
                     10.2.1.1. Standard PCR Systems
                     10.2.1.2. RT PCR Systems
                     10.2.1.3. Digital PCR Systems
            10.2.2. Reagents
            10.2.3. Consumables
     10.3. Market Value Forecast, by End-user, 2016–2026
            10.3.1. Pharmaceutical and Biotechnology Industries
            10.3.2. Clinical Diagnostics Labs and Hospitals
            10.3.3. Academic and Research Organizations
            10.3.4. Others
     10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
            10.4.1. Germany
            10.4.2. U.K.
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Rest of Europe
     10.5. Market Attractiveness Analysis
            10.5.1. By Product
            10.5.2. By End-user
            10.5.3. By Country/Sub-region

11. Asia Pacific PCR Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast, by Product, 2016–2026
            11.2.1. Instruments
                     11.2.1.1. Standard PCR Systems
                     11.2.1.2. RT PCR Systems
                     11.2.1.3. Digital PCR Systems
            11.2.2. Reagents
            11.2.3. Consumables
     11.3. Market Value Forecast, by End-user, 2016–2026
            11.3.1. Pharmaceutical and Biotechnology Industries
            11.3.2. Clinical Diagnostics Labs and Hospitals
            11.3.3. Academic and Research Organizations
            11.3.4. Others
     11.4. Market Value Forecast, by Country/Sub-region, 2016–2026
            11.4.1. China
            11.4.2. Japan
            11.4.3. India
            11.4.4. Australia & New Zealand
            11.4.5. Rest of Asia Pacific
     11.5. Market Attractiveness Analysis
            11.5.1. by Product
            11.5.2. by End-user
            11.5.3. by Country/Sub-region

12. Rest of the World PCR Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast, by Product, 2016–2026
            12.2.1. Instruments
                     12.2.1.1. Standard PCR Systems
                     12.2.1.2. RT PCR Systems
                     12.2.1.3. Digital PCR Systems
            12.2.2. Reagents
            12.2.3. Consumables
     12.3. Market Value Forecast, by End-user, 2016–2026
            12.3.1. Pharmaceutical and Biotechnology Industries
            12.3.2. Clinical Diagnostics Labs and Hospitals
            12.3.3. Academic and Research Organizations
            12.3.4. Others
     12.4. Market Attractiveness Analysis
            12.4.1. by Product
            12.4.2. by End-user

13. Competition Landscape
     13.1. Market Player – Competition Matrix Competition Matrix (by Tier and Size of Companies)
     13.2. Market Share Analysis by Company (2017)
     13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.3.1. Bio-Rad Laboratories, Inc.
                     13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.1.2. Product Portfolio
                     13.3.1.3. SWOT Analysis
                     13.3.1.4. Financial Overview
                     13.3.1.5. Strategic Overview
            13.3.2. Qiagen N.V.
                     13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.2.2. Product Portfolio
                     13.3.2.3. SWOT Analysis
                     13.3.2.4. Financial Overview
                     13.3.2.5. Strategic Overview
            13.3.3. F. Hoffmann-La Roche AG
                     13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.3.2. Product Portfolio
                     13.3.3.3. SWOT Analysis
                     13.3.3.4. Financial Overview
                     13.3.3.5. Strategic Overview
            13.3.4. Thermo Fisher Scientific, Inc.
                     13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.4.2. Product Portfolio
                     13.3.4.3. SWOT Analysis
                     13.3.4.4. Financial Overview
                     13.3.4.5. Strategic Overview
            13.3.5. Becton, Dickinson and Company
                     13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.5.2. Product Portfolio
                     13.3.5.3. SWOT Analysis
                     13.3.5.4. Financial Overview
                     13.3.5.5. Strategic Overview
            13.3.6. Abbott
                     13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.6.2. Product Portfolio
                     13.3.6.3. SWOT Analysis
                     13.3.6.4. Financial Overview
                     13.3.6.5. Strategic Overview
            13.3.7. Siemens Healthcare GmbH (Siemens AG)
                     13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.7.2. Product Portfolio
                     13.3.7.3. SWOT Analysis
                     13.3.7.4. Financial Overview
                     13.3.7.5. Strategic Overview
            13.3.8. BioMérieux SA
                     13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.8.2. Product Portfolio
                     13.3.8.3. SWOT Analysis
                     13.3.8.4. Financial Overview
                     13.3.8.5. Strategic Overview
            13.3.9. Danaher Corporation
                     13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.9.2. Product Portfolio
                     13.3.9.3. SWOT Analysis
                     13.3.9.4. Financial Overview
                     13.3.9.5. Strategic Overview
            13.3.10. Agilent Technologies
                     13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.10.2. Product Portfolio
                     13.3.10.3. SWOT Analysis
                     13.3.10.4. Financial Overview
                     13.3.10.5. Strategic Overview

List of Tables

Table 01: Global PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 03: Global PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global PCR Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America PCR Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 08: North America PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: U.S. PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 10: U.S. PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Canada PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 12: Canada PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Europe PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Europe PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 15: Europe PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 16: Europe PCR Market Size (US$ Mn) Forecast, by Industry, 2016–2026
Table 17: Germany PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 18: Germany PCR Market Size (US$ Mn) Forecast, of Industry, 2016–2026
Table 19: France PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 20: France PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 21: Italy PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Italy PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 23: U.K. PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 24: U.K. PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 25: Russia PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Russia PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 27: Spain PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 28: Spain PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 29: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 31: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 32: Asia Pacific PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 33: China PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 34: China PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 35: India PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 36: India PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 37: Japan PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Japan PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 40: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 41: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 42: Rest of the World PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 43: Rest of the World PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 44: Rest of the World PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global PCR Market Snapshot
Figure 02: Global PCR Market Size (US$ Mn) Forecast, 2016–2026
Figure 04: Global PCR Market Value Share (%), by End-user (2017)
Figure 05: Global PCR Market Value Share (%), by Region (2017)
Figure 03: Global PCR Market Value Share (%), by Product (2017)
Figure 06: Global PCR Market Value Share (%), by Product, 2017 and 2026
Figure 07: Global PCR Market Attractiveness, by Product, 2018–2026
Figure 08: Global PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Instruments Method, 2016–2026
Figure 09: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents Method, 2016–2026
Figure 10: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Consumables Method, 2016–2026
Figure 11: Global PCR Market Value Share (%), by End-user, 2017 and 2016
Figure 12: Global PCR Market Value Share (%), by End-user, 2017 and 2016
Figure 13: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Industries, 2018–2026
Figure 14: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Diagnostics Labs and Hospitals, 2018–2026
Figure 15: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic and Research Organizations, 2018–2026
Figure 16: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2018–2026
Figure 17: Global PCR Market Attractiveness, by Region, 2018–2026
Figure 18: Global PCR Market Value Share (%), by Region, 2017 and 2016
Figure 19: North America PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 20: North America PCR Market Value Share, by Country, 2017 and 2026
Figure 21: North America PCR Market Attractiveness, by Country, 2018–2026
Figure 22: North America PCR Market Value Share (%), by Product, 2017 and 2026
Figure 23: North America PCR Market Attractiveness, by Product, 2018–2026
Figure 24: North America PCR Market Value Share (%), by End-user, 2017 and 2026
Figure 25: North America PCR Market Attractiveness, by End-user, 2018–2026
Figure 26: Europe PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 27: Europe PCR Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 28: Europe PCR Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 29: Europe PCR Market Value Share (%), by Product, 2017 and 2026
Figure 30: Europe PCR Market Attractiveness, by Product, 2018 and 2026
Figure 31: Europe PCR Market Value Share (%), by Industry, 2017 and 2026
Figure 32: Europe PCR Market Attractiveness, by Industry, 2018-2026
Figure 33: Asia Pacific PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 34: Asia Pacific PCR Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 35: Asia Pacific PCR Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 36: Asia Pacific PCR Market Value Share (%), by Product, 2017 and 2026
Figure 37: Asia Pacific PCR Market Attractiveness, by Product, 2018–2026
Figure 38: Asia Pacific PCR Market Value Share (%), by End-user, 2017 and 2026
Figure 39: Asia Pacific PCR Market Attractiveness, by End-user, 2018–2026
Figure 40: Rest of the World PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 41: Rest of the World Mexico PCR Market Value Share (%), by Product, 2017 and 2026
Figure 42: Rest of the World Mexico PCR Market Attractiveness, by Product, 2018–2026
Figure 43: Rest of the World Mexico PCR Market Value Share (%), by End-user, 2017 and 2026
Figure 44: Rest of the World Mexico PCR Market Attractiveness, by End-user, 2018–2026
Figure 45: Company Share Analysis (%), 2017 
Figure 46 Bio-Rad Laboratories, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 47: Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Region, 2017
Figure 48: Bio-Rad Laboratories, Inc.  Breakdown of Net Sales, by Business Segment, 2017
Figure 49: Qiagen N.V. Breakdown of Net Sales, by Product Category, 2017
Figure 50: Qiagen N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 51: Qiagen N.V. Breakdown of Net Sales, by Region, 2017
Figure 52: F. Hoffmann-La Roche AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 53: F. Hoffmann-La Roche AG R&D Expenses, 2016–2017
Figure 54: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Business Division, 2017
Figure 55: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Segment), by Region, 2017
Figure 56: Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 57: Thermo Fisher Scientific, Inc. R & D Expenses, 2015-2017
Figure 58: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2017
Figure 59: Thermo Fisher Scientific, Inc.  Breakdown of Net Sales, by Business Segment, 2017
Figure 60: Becton, Dickinson and Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 61: Becton, Dickinson and Company R&D Intensity and Sales & Marketing Intensity – Company Level, (US$ Mn), 2016–2017
Figure 62: Becton, Dickinson and Company Breakdown of Net Sales, by Region, 2017
Figure 63: Becton, Dickinson and Company Breakdown of Net Sales, by Business Segment, 2017
Figure 64: Abbott Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 65: Abbott R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 66: Abbott Breakdown of Net Sales, by Segment, 2017
Figure 67: Abbott Breakdown of Net Sales (%), by Country, 2017
Figure 68: Siemens Healthcare GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 69: Siemens Healthcare GmbH Diagnostics Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 70: Siemens Healthcare GmbH General and Administration Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 71: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Region, 2017
Figure 72: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Business Segment, 2017
Figure 73: bioMérieux SA Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 74: bioMérieux SA R & D Expenses (US$ Bn), 2015-2017
Figure 75: bioMérieux SA Breakdown of Net Sales, by Region, 2017
Figure 76: bioMérieux SA Breakdown of Net Sales, by Segment, 2017
Figure 77: Danaher Corporation Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 78: Danaher Corporation R & D Expenses
Figure 79: Danaher Corporation Breakdown of Net Sales, by Region, 2017
Figure 80: Danaher Corporation Breakdown of Net Sales, by Segment, 2017
Figure 81: Agilent Technologies Breakdown of Net Sales, by Segment, 2017
Figure 82: Agilent Technologies Breakdown of Net Sales, by Region, 2017
Figure 83: Agilent Technologies Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017

.